LIPID PROFILE IN SMOKING
Abstract
Background: Smoking is one of the major risk factors in the genesis of coronary atherosclerosis and development ofcoronary heart disease. Smoking which is recognized as a major risk factor for the development of ischaemic heart
disease may lead to alter the normal plasma lipoprotein pattern. Methods: Fifty adult smokers were selected along
with thirty normal controls. Lipid profile was studied and estimations of cholesterol, total lipids, triglycerides. HDL.
LDL. VLDL and chylomicrons were made. Results: All these parameters except HDL level were significantly
increased in smokers while HDL level was significantly decreased, showing greater risk of these persons to
atherosclerosis and coronary heart disease (CHD). Various ratios like LDL/HDL. VLDL/HDL. TG/HDL and TC/HDL
were calculated to find out the risk of atherosclerosis and CHD so that early measures could be adopted to avoid
complicated disease process.
References
Thelle, D.S. & Sharper. AG. Blood lipids in middleaged British men. Br. Heart...! 19X3: 49:205-13.
White, P.D. Coronary disease & coronary thrombosis
in youth. J. Med. Soc. J. 1935:32: 596-605
Framingham Study: Paul Sorlie & Tavia Gorden Body
build & mortality. JAMA, 1980: May 9, Vol. 243.
Doll, R. & Hill, A.B. Mortality in relation to smoking.
Br. Med. J. 1964: ii: 399-440.
Friedman, G.D. & Dale, L. G. Mortality in middle-aged
smokers & non-smokers. N. Engl. J. Med. 1979: 300-
Stamler. J. Wentworth D. Is the relationship between
serum cholesterol & risk of premature death from
coronary heart disease continuous & graded? JAMA
: 256:2823-28.
Garrison, R.J. Kannel, W.B. Cigarette smoking &
I1DL- cholesterol. Atherosclerosis: 1979: 30,17.
Bain, C. & Jesse M.J. Cigarette consumption and deaths
from coronary artery disease. Lancet, 1978:1:1087-8.
Cook, D. Cr. & Sharper. A. G. Giving up smoking and
the risk of heart attacks. A Report from British Regional
Study. Lancet: 1986:12.
Cluette-Brown. J. & Hugan. S. Oral nicotine induces an
atherogenic lipoprotein profile. Proc. Soc. Exp. Bio.
Med 1986:182:409-13.
Hojnack, J. Mulligan, J.& Cluette-Brown J. Oral
nicotine impairs clearance of plasma Low Density
Lipoproteins. Proc. Soc. Exp. Biol. Med.
:182:414-18.
Ramsdale. D.R.& Bened D. Smoking & coronary artery
disease assessed by routine coronary arteriography.
Brit. Med. J. 1985: 290; 197-200.
Augustin, J. & Beedgen, B. The influence of smoking
on plasma lipoproteins. Intern Med. 1982: 9: 104-8.
Gorden, T. Castelli. W.P. Diabetes, blood lipids and the
role of obesity in coronary heart disease risk for
women. The Framingham Study. Ann. Intern. Med.
: 83:393-397.
Dawber, T. R. Kannel, W.B. & Gorden, T. Some
factors associated with the development of coronary
heart disease. Am. J. Publ. Health: 1959: 49: 1349-56.
Goldbourt U, Holtlman E. Total & high density
lipoprotein cholesterol in the serum & risk of mortality.
BMJ; 1985: Vol. 290:1239-12-42.
Varley, H. Gowenlock, H.A. and Bell. M. (Editors)
Practical clinical biochemistry. Vol. l, 5th.
William heinemann Medical Books Ltd. London. P677.
Carlson. L.A., Bottiger L.E. Ischaemic heart disease in
relation to fasting values of plasma triglycerides and
cholesterol. Stockholm Prospective Study. Lancet.
:865.
Multiple Risk Factor Intervention Trial Research group
(MRFIT): JAMA: 1982: 248: 1465-77.
Martin M. J. Hulley S.B. Serum Cholesterol, B.P &
mortality. Lancet; 1986.:2:933-36.
Kesaneimi, Y.A. and Grundy. Significance of low
density lipoprotein production in the regulation of
plasma cholesterol level in men. J. clin. Invest. 1982:
Vol. 70:13-22.
Kannel W.B. Metabolic risk factor for coronary heart
disease in women. Am. Heart. J. 1987:114:413-19.
Castelli WP. Cardiovascular disease in women. AM.J.
Obstet. Gynaecol. 1988: 1046-1060.
Guyton. C. Female Physiology before pregnancy and
female hormones, in text book of Medical Physiology'
th Ed. W.B. Saunders company Philadelphia 1991 pp
Razay G, Heaton KW, Boltan CH. coronary heart
disease risk factors in relation to manpower. Quarterly
J. med. 1992; 889-96
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
